cetrorelix- cetrorelix acetate kit
akorn - cetrorelix acetate (unii: w9y8l7gp4c) (cetrorelix - unii:oon1hfz4ba) - cetrorelix acetate for injection is indicated for the inhibition of premature lh surges in women undergoing controlled ovarian stimulation. cetrorelix acetate for injection is contraindicated under the following conditions: - hypersensitivity to cetrorelix acetate, extrinsic peptide hormones or mannitol. - known hypersensitivity to gnrh or any other gnrh analogs. - known or suspected pregnancy, and lactation (see precautions). - severe renal impairment
cetrotide- cetrorelix acetate kit
emd serono, inc. - cetrorelix acetate (unii: w9y8l7gp4c) (cetrorelix - unii:oon1hfz4ba) - cetrorelix 0.25 mg in 1 ml - cetrotide® (cetrorelix acetate for injection) is indicated for the inhibition of premature lh surges in women undergoing controlled ovarian stimulation. cetrotide® (cetrorelix acetate for injection) is contraindicated under the following conditions: - hypersensitivity to cetrorelix acetate, extrinsic peptide hormones or mannitol. - known hypersensitivity to gnrh or any other gnrh analogs. - known or suspected pregnancy, and lactation (see precautions). - severe renal impairment
cetrorelix- cetrorelix acetate kit
teva pharmaceuticals, inc. - cetrorelix acetate (unii: w9y8l7gp4c) (cetrorelix - unii:oon1hfz4ba) - cetrorelix acetate for injection is indicated for the inhibition of premature lh surges in women undergoing controlled ovarian stimulation. cetrorelix acetate for injection is contraindicated under the following conditions: - hypersensitivity to cetrorelix acetate, extrinsic peptide hormones or mannitol. - known hypersensitivity to gnrh or any other gnrh analogs. - known or suspected pregnancy, and lactation (see precautions). - severe renal impairment
cetrotide cetrorelix 250 microgram (as acetate) powder for injection vial with diluent syringe
merck healthcare pty ltd - cetrorelix, quantity: 0.25 mg - injection, powder for - excipient ingredients: mannitol - indications: prevention of premature luteinization and ovulation in patients undergoing a controlled ovarian stimulation, followed by oocyte pick up and assisted reproductive techniques. in clinical trials cetrotide was used with human menopausal gonadotrophin (hmg), however limited experience with recombinant fsh suggested similar efficacy.
cetrotide injection 0.25 mg
merck pte. ltd. - cetrorelix (as cetrorelix acetate) - injection - 0.25 mg - cetrorelix (as cetrorelix acetate) 0.25 mg
cetrotide
pharmacy retailing (nz) ltd t/a healthcare logistics - cetrorelix acetate 0.26mg equivalent to 0.25 mg cetrorelix - injection with diluent - 250 mcg - active: cetrorelix acetate 0.26mg equivalent to 0.25 mg cetrorelix excipient: mannitol water for injection - prevention of premature luteinization and ovulation in patients undergoing a controlled ovarian stimulation, followed by oocyte pick up and assisted reproductive techniques.
cetrotide
pharmacy retailing (nz) ltd t/a healthcare logistics - cetrorelix acetate 3.12mg equivalent to 3.00 mg cetrorelix - injection with diluent - 3 mg - active: cetrorelix acetate 3.12mg equivalent to 3.00 mg cetrorelix excipient: mannitol water for injection - prevention of premature luteinization and ovulation in patients undergoing a controlled ovarian stimulation, followed by oocyte pick up and assisted reproductive techniques.
cetrotide powder for solution
emd serono, a division of emd inc., canada - cetrorelix (cetrorelix acetate) - powder for solution - 3mg - cetrorelix (cetrorelix acetate) 3mg - gonadotropin-releasing hormone antagonists
ceziboe 0,25 mg inj. sol. s.c. pre-filled syr.
sun pharmaceutical industries europe b.v. - cetrorelix acetate - eq. cetrorelix 0,25 mg/ml - solution for injection in pre-filled syringe - 0,25 mg - cetrorelix acetate - cetrorelix
cetrotide powder for solution
emd serono, a division of emd inc., canada - cetrorelix (cetrorelix acetate) - powder for solution - 0.25mg - cetrorelix (cetrorelix acetate) 0.25mg - gonadotropin-releasing hormone antagonists